Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€13.00
28.06.24
€20.55
28.06.25
-15.38%
26.09.24

buy
Rekor Systems Inc.

Start price
Target price
Perf. (%)
€1.42
27.06.24
-
27.07.24
18.96%
28.07.24

buy
Rivian Automotive Inc.

Start price
Target price
Perf. (%)
€13.50
26.06.24
-
26.07.24
12.59%
27.07.24

buy
Vertiv Holdings Co.

Start price
Target price
Perf. (%)
€81.22
26.06.24
-
26.07.24
-12.08%
27.07.24

buy
Ama Corporation Plc

Start price
Target price
Perf. (%)
€5.84
26.06.24
€0.25
26.07.24
-
27.07.24

buy
Coherent Corp.

Start price
Target price
Perf. (%)
€139.00
26.06.24
-
26.07.24
-
27.07.24

buy
Arm Holdings Plc

Start price
Target price
Perf. (%)
€153.40
26.06.24
€200.00
27.06.26
8.08%
06.07.24

Alfen

Start price
Target price
Perf. (%)
€16.72
26.06.24
€20.00
26.06.25
-23.24%
04.10.24

buy
Nikola Corp.

Start price
Target price
Perf. (%)
€0.32
26.06.24
-
26.07.24
-
27.07.24

buy
Alfen

Start price
Target price
Perf. (%)
€15.50
26.06.24
-
26.06.25
17.65%
06.07.24

Could be worthwhile Investment >10% per year
Scinai Immunotherapeutics Ltd.

Start price
Target price
Perf. (%)
€2.96
26.06.24
-
26.06.25
70.61%
16.07.24

Nikola Corp.

Start price
Target price
Perf. (%)
€0.32
26.06.24
-
26.07.24
-
27.07.24

buy
United Homes Group Inc.

Start price
Target price
Perf. (%)
€5.70
26.06.24
€9.50
26.06.25
-12.63%
08.07.24

Could be very worthwhile Investment >20% year
Regis Corp. (minn.)

Start price
Target price
Perf. (%)
€16.30
26.06.24
-
26.06.25
28.83%
07.07.24

Probably not worthwhile Investment
Regis Corp. (minn.)

Start price
Target price
Perf. (%)
€16.30
26.06.24
-
26.06.25
52.15%
02.10.24

Innovative
Bad culture
Below average Management
Probably not worthwhile Investment
buy
Alimera Sciences Inc.

Start price
Target price
Perf. (%)
€5.13
25.06.24
-
25.06.25
-1.95%
06.09.24

Management is a major shareholder
buy
Nikola Corp.

Start price
Target price
Perf. (%)
€0.32
25.06.24
-
25.07.24
-
26.07.24

buy
Cardiol Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.85
25.06.24
-
25.06.25
-0.22%
06.07.24

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Standard Investments for future growth
negative Cash Flow expected
Ocugen Inc.

Start price
Target price
Perf. (%)
€1.18
25.06.24
-
25.06.25
32.23%
06.07.24

Normal challenges to pay loans and raise capital
High valuation
Risky balance sheet
Revenue decline/stagnation expected
Scinai Immunotherapeutics Ltd.

Start price
Target price
Perf. (%)
€3.12
25.06.24
-
25.06.25
-12.18%
06.07.24

Probably not worthwhile Investment
Little Investments for future growth
Revenue decline/stagnation expected
High valuation
buy
Beyond Air Inc.

Start price
Target price
Perf. (%)
€0.93
25.06.24
-
25.06.25
-58.28%
04.10.24

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Little innovation
buy
Scinai Immunotherapeutics Ltd.

Start price
Target price
Perf. (%)
€3.12
25.06.24
€15.00
25.06.25
-12.18%
07.07.24

buy
Annovis Bio Inc.

Start price
Target price
Perf. (%)
€5.60
25.06.24
-
25.06.25
88.93%
06.07.24

Annovis Bio Inc.

Start price
Target price
Perf. (%)
€5.71
24.06.24
-
24.06.25
74.61%
05.07.24

Risky Investment
buy
Effector Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.29
24.06.24
-
24.06.25
-41.99%
06.07.24